The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model

Tatsuzo Mizukami(Hokkaido University), Akinobu Taketomi(Hokkaido University)
Oncotarget
September 18, 2018
Cited by 33


Related Papers